Advanced glycation end-products and the progress of diabetic vascular complications.

scientific article published on January 2004

Advanced glycation end-products and the progress of diabetic vascular complications. is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P698PubMed publication ID15046548

P2093author name stringN Rietbrock
V Jakus
P433issue2
P304page(s)131-142
P577publication date2004-01-01
P1433published inPhysiological ResearchQ15757549
P1476titleAdvanced glycation end-products and the progress of diabetic vascular complications
P478volume53

Reverse relations

cites work (P2860)
Q59809890A Network Pharmacology Approach to Uncover the Mechanisms of Shen-Qi-Di-Huang Decoction against Diabetic Nephropathy
Q36979205A glimpse of various pathogenetic mechanisms of diabetic nephropathy
Q42577428Abnormalities in the brain of streptozotocin-induced type 1 diabetic rats revealed by diffusion tensor imaging
Q44686047Advanced glycation end products and diabetic nephropathy: a comparative study using diabetic and normal rats with methylglyoxal-induced glycation.
Q35512499Advanced glycation end-products induce apoptosis in pancreatic islet endothelial cells via NF-κB-activated cyclooxygenase-2/prostaglandin E2 up-regulation.
Q54599158Advanced glycation end-products induce heparanase expression in endothelial cells by the receptor for advanced glycation end products and through activation of the FOXO4 transcription factor.
Q47121856Advanced glycation endproducts link inflammatory cues to upregulation of galectin-1 in diabetic retinopathy
Q92346511Almond-supplemented diet improves sexual functions beyond Phosphodiesterase-5 inhibition in diabetic male rats
Q37450074Analysis of Retina and Erythrocyte Glycerophospholipid Alterations in a Rat Model of Type 1 Diabetes.
Q46309845Anti-hyperglycemic effect of the aqueous extract of banana infructescence stalks in streptozotocin-induced diabetic rats
Q46015543Antihyperglycemic, antioxidant and antiglycation activities of mulberry leaf extract in streptozotocin-induced chronic diabetic rats.
Q43144920Antioxidant and antiglycation properties of triterpenoid saponins from Aralia taibaiensis traditionally used for treating diabetes mellitus
Q92024846B procyanidins of Annona crassiflora fruit peel inhibited glycation, lipid peroxidation and protein-bound carbonyls, with protective effects on glycated catalase
Q40361355Cardiovascular dementia - a different perspective
Q36294234Circulating TGF-β1, glycation, and oxidation in children with diabetes mellitus type 1.
Q47181674Combined Metabolomic Analysis of Plasma and Urine Reveals AHBA, Tryptophan and Serotonin Metabolism as Potential Risk Factors in Gestational Diabetes Mellitus (GDM).
Q33411830Comparative analysis of coherent light action (laser) versus non-coherent light (light-emitting diode) for tissue repair in diabetic rats
Q36335124Continuous Glucose Monitoring Systems: A Review
Q36026951Cyanidin-3-rutinoside attenuates methylglyoxal-induced protein glycation and DNA damage via carbonyl trapping ability and scavenging reactive oxygen species
Q37694160DNA Advanced Glycation End Products (DNA-AGEs) Are Elevated in Urine and Tissue in an Animal Model of Type 2 Diabetes.
Q33840246Detection of autoantibodies against reactive oxygen species modified glutamic acid decarboxylase-65 in type 1 diabetes associated complications
Q91583464Diabetes, a Contemporary Risk for Parkinson's Disease: Epidemiological and Cellular Evidences
Q38542115Diabetic Retinopathy: Vascular and Inflammatory Disease.
Q39208422Diabetic retinopathy: new therapeutic perspectives based on pathogenic mechanisms.
Q35670859Dietary advanced glycation end products and aging
Q60929757Discriminating high-risk cervical Human Papilloma Virus infections with urinary biomarkers via non-targeted GC-MS-based metabolomics
Q24813839Distinct effects of glucose and glucosamine on vascular endothelial and smooth muscle cells: evidence for a protective role for glucosamine in atherosclerosis
Q35843905Effects of High Glucose Levels and Glycated Serum on GIP Responsiveness in the Pancreatic Beta Cell Line HIT-T15.
Q33746869Effects of a new advanced glycation inhibitor, LR-90, on mitigating arterial stiffening and improving arterial elasticity and compliance in a diabetic rat model: aortic impedance analysis
Q37773162Endothelial dysfunction, inflammation, and apoptosis in diabetes mellitus
Q49923465Evolving Mechanisms of Vascular Smooth Muscle Contraction Highlight Key Targets in Vascular Disease
Q36808421Examining the role of lipid mediators in diabetic retinopathy
Q47101820Functional Effects of Alagebrium (ALT-711)-Isolated Rat Carotid Artery
Q41038156Global Autorecognition and Activation of Complement by Mannan-Binding Lectin in a Mouse Model of Type 1 Diabetes
Q43108062Glucagon-like peptide-1 (GLP-1) protects vascular endothelial cells against advanced glycation end products (AGEs)-induced apoptosis.
Q92451047Glycation of macrophages induces expression of pro-inflammatory cytokines and reduces phagocytic efficiency
Q34517974Glycoxidative stress and cardiovascular complications in experimentally-induced diabetes: effects of antioxidant treatment
Q60308806Gold Nanoparticle-Based Detection of Low Molecular Weight AGEs from In Vitro Glycated Haemoglobin A0 Samples
Q35891564High-mobility group box 1 protein is implicated in advanced glycation end products-induced vascular endothelial growth factor A production in the rat retinal ganglion cell line RGC-5.
Q36653997Host-directed therapy targeting the Mycobacterium tuberculosis granuloma: a review
Q36900791Hyperglycemic oxoaldehyde, glyoxal, causes barrier dysfunction, cytoskeletal alterations, and inhibition of angiogenesis in vascular endothelial cells: aminoguanidine protection.
Q36181550In vitro inhibitory activities of selected Australian medicinal plant extracts against protein glycation, angiotensin converting enzyme (ACE) and digestive enzymes linked to type II diabetes
Q37673039Increased levels of circulating advanced glycation end-products in menopausal women with osteoporosis
Q34699172Is the present cut-point to define type 2 diabetes appropriate in Latin-Americans?
Q40962114Light Modulates Ocular Complications in an Albino Rat Model of Type 1 Diabetes Mellitus
Q48170304Long-term physical activity leads to a significant increase in serum sRAGE levels: a sign of decreased AGE-mediated inflammation due to physical activity?
Q87449038Malonyldialdehyde and glyoxal act differently on low-density lipoproteins and endotheliocytes
Q26745606Microvasular and macrovascular complications in diabetes mellitus: Distinct or continuum?
Q34212843Modulation of renal-specific oxidoreductase/myo-inositol oxygenase by high-glucose ambience.
Q38290105Molecular mechanisms of AGE/RAGE-mediated fibrosis in the diabetic heart
Q36747958Myoglobin-H2O2 catalyzes the oxidation of β-ketoacids to α-dicarbonyls: mechanism and implications in ketosis
Q38330385Oxidative Stress in Alzheimer's Disease: Should We Keep Trying Antioxidant Therapies?
Q37003803Oxidative Stress in Diabetic Nephropathy
Q35998796Pathophysiological role of enhanced bone marrow adipogenesis in diabetic complications.
Q45918336Peroxynitrite mediates glomerular lesion of diabetic rat via JAK/STAT signaling pathway.
Q52609620Potential Interplay between Hyperosmolarity and Inflammation on Retinal Pigmented Epithelium in Pathogenesis of Diabetic Retinopathy.
Q38610999Protective effect of hydroalcoholic extract of Teucrium polium on diabetes-induced testicular damage and serum testosterone concentration
Q47131231Protein Kinase C as Regulator of Vascular Smooth Muscle Function and Potential Target in Vascular Disorders
Q35888805RAGE and AGEs in Mild Cognitive Impairment of Diabetic Patients: A Cross-Sectional Study
Q37642065Renal-protective effect of nicousamide on hypertensive nephropathy in spontaneously hypertensive rats
Q35929112Role of advanced glycation end products in cardiovascular disease.
Q27003423Role of advanced glycation end products in cellular signaling
Q37370688Role of advanced glycation end products with oxidative stress in resistance artery dysfunction in type 2 diabetic mice
Q38270180Role of protein kinase C in podocytes and development of glomerular damage in diabetic nephropathy
Q42957259Role of the receptor for advanced glycation end products in hepatic fibrosis
Q36956727Rosiglitazone reduces renal and plasma markers of oxidative injury and reverses urinary metabolite abnormalities in the amelioration of diabetic nephropathy.
Q33783975TRB3 mediates advanced glycation end product-induced apoptosis of pancreatic β-cells through the protein kinase C β pathway
Q35694364The Effects of Leucine, Zinc, and Chromium Supplements on Inflammatory Events of the Respiratory System in Type 2 Diabetic Rats
Q37066216The action of aminoguanidine on the liver of trained diabetic rats
Q41651498The role of acetoacetate in Amadori product formation of human serum albumin.
Q37716694Trends in advanced glycation end products research in diabetes mellitus and its complications.
Q91638921Triamcinolone acetonide combined with aminoguanidine inhibits inflammation and oxidative stress, improves vascular endothelial and retinal function and reduces VEGF expression in diabetic retinopathy patients
Q64235010Troxerutin affects the male fertility in prepubertal type 1 diabetic male rats
Q35774506Using Serum Advanced Glycation End Products-Peptides to Improve the Efficacy of World Health Organization Fasting Plasma Glucose Criterion in Screening for Diabetes in High-Risk Chinese Subjects
Q37091098Vitamin C intake reduces the cytotoxicity associated with hyperglycemia in prediabetes and type 2 diabetes
Q27028225Vitreous mediators in retinal hypoxic diseases

Search more.